|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 487/10 | (2006.01) |
| A61K 31/397 | (2006.01) | ||
| A61K 31/407 | (2006.01) |
| (11) | Number of the document | 2951183 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14703747.7 |
| Date of filing the European patent application | 2014-01-29 | |
| (97) | Date of publication of the European application | 2015-12-09 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-13 |
| (46) | Date of publication of the claims translation | 2019-05-27 |
| (86) | Number | PCT/US2014/013619 |
| Date | 2014-01-29 |
| (87) | Number | WO 2014/120783 |
| Date | 2014-08-07 |
| (30) | Number | Date | Country code |
| 201361757903 P | 2013-01-29 | US |
| (72) |
LOWE, John, A., III, US
KHAN, M., Amin, US
|
| (73) |
Aptinyx Inc.,
1801 Maple Avenue, Suite 4300, Evanston, IL 60201,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Spiro-laktamo NMDA receptorių moduliatoriai ir jų panaudojimas |
| SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2023-01-02 | 10 | 231.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-01-29 |